Growth Metrics

Idexx Laboratories (IDXX) Cash from Operations (2016 - 2026)

Idexx Laboratories has reported Cash from Operations over the past 17 years, most recently at 355760000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 35.77% year-over-year to 355760000.0; the TTM value through Dec 2025 reached 1181805000.0, up 27.21%, while the annual FY2025 figure was 1181805000.0, 27.21% up from the prior year.
  • Cash from Operations for Q4 2025 was 355760000.0 at Idexx Laboratories, down from 402340000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 402340000.0 in Q3 2025 and troughed at 65850000.0 in Q2 2022.
  • A 5-year average of 215792300.0 and a median of 205139000.0 in 2021 define the central range for Cash from Operations.
  • Biggest five-year swings in Cash from Operations: skyrocketed 346.42% in 2021 and later tumbled 71.85% in 2022.
  • Year by year, Cash from Operations stood at 209964000.0 in 2021, then dropped by 17.4% to 173428000.0 in 2022, then soared by 44.07% to 249851000.0 in 2023, then rose by 4.87% to 262025000.0 in 2024, then surged by 35.77% to 355760000.0 in 2025.
  • Business Quant data shows Cash from Operations for IDXX at 355760000.0 in Q4 2025, 402340000.0 in Q3 2025, and 185743000.0 in Q2 2025.